Corvus Pharmaceuticals (CRVS) PT Lowered to $8 at Wedbush
Tweet
Share
E-mailGet Alerts CRVS Hot Sheet
Price: $15.14 --0%
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
14 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Wedbush analyst Robert Driscoll lowered the price target on Corvus Pharmaceuticals (NASDAQ: CRVS) to $8.00 (from $11.00) while maintaining a Outperform rating.
You May Also Be Interested In
- TerraVest Industries Inc (TVK:CN) PT Raised to Cdn$170 at BMO Capital
- Melco Resorts (MLCO) PT Lowered to $7 at Susquehanna
- Aya Gold & Silver Inc (AYA:CN) (MYAGF) PT Raised to Cdn$41 at BMO Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
